KALV KalVista Pharmaceuticals, Inc.

$27.00▲ +0.00% Healthcare Other
Volume 4.26M Avg Volume (10D) 2.09M
Key Metrics & Fundamentals
Market Cap
$1.44B
P/E Ratio
–
Div Yield
–%
52W Range
9.83 - 27.00
% vs 50 MA
11.14%
% vs 200 MA
–%
RSI-14
75.9
MACD Histogram
-0.2100
Beta (1Y vs SPY)
0.87
Free Cash Flow
-$14.66M
Gross Rev
$40.86M
Gross Profit
$37.77M
EBITDA
-$17.49M
COGS
$3.09M
Operating Exp
$61.22M
Operating Income
-$23.44M
EBIT
-$23.44M
Pretax Income
-$23.49M
Net Income
-$23.49M
EPS (Diluted)
-0.43
Price & Volume History
Loading chart…
Recent News
No recent news found for KALV.
Financial Overview - Income Statement Quarterly

See KALV's money flow as a full page

Social Sentiment
Avg +0.88 · 6 posts
NewsTradePriceTarget$KALV ($15.06) KalVista FDA breakout. First oral HAE drug + bullish options setup
r/options · Jul 8, 2025
Significant price increase following FDA approval, bullish options, and high volume indicate strong positive sentiment.
very_positive +1.00
DDNewsTradePriceTarget[KALV] FDA APPROVED 🚀 | First-in-class oral HAE drug is here — buckle up
r/wallstreetbets · Jul 7, 2025
Strong bullish sentiment driven by FDA approval, market exclusivity, and potential for a significant price increase.
very_positive +1.00
TradeDiscussionNewsI bet the whole damn account on $KALV – FDA roulette edition 🎰💊
r/wallstreetbets · Jun 25, 2025
High confidence in the company's potential, driven by FDA approval anticipation and a successful recovery.
very_positive +0.80
DDTradeMemeI bet the whole damn account on $KALV – FDA roulette edition 🎰💊
r/wallstreetbets · Jun 25, 2025
The poster expresses extreme confidence and excitement about the stock's potential following the FDA decision, describing it as a 'victory pizza' scenario.
very_positive +0.90
TradeMy Current Watchlist & Options For 6/16/25
r/wallstreetbets · Jun 17, 2025
Clear trading plan with target and stop-loss, signifying potential investment.
positive +0.70
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙